Drug design strategies with metal-hydroxyquinoline complexes

References

• Savic-Gajic I, Savic I, Gajic D. The role and health risk of heavy metals in human organism. In: Castillo L, editor. Heavy metals and health. USA: Nova Science Publishers: Inc.; 2016. p. 47–89.
   Google Scholar
• Gao P, Sun L, Zhou J, et al. Discovery of novel anti-HIV agents via Cu (I)-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry-based approach. Expert Opin Drug Dis. 2016;11(9):857–871.
   PubMed Web of Science ®Google Scholar
• Spinello A, Magistrato A. An omics perspective to the molecular mechanisms of anticancer metallo-drugs in the computational microscope era. Expert Opin Drug Dis. 2017;12(8):813–825.
   PubMed Web of Science ®Google Scholar
• Solmaz U, Gumus I, Binzet G, et al. Synthesis, characterization, crystal structure, and antimicrobial studies of novel thiourea derivative ligands and their platinum complexes. J Coord Chem. 2018;71(2):200–218.
   Web of Science ®Google Scholar
• Dandawate P, Padhye S, Schobert R, et al. Discovery of natural products with metal-binding properties as promising antibacterial agents. Expert Opin Drug Dis. 2019;14(6):563–576.
   PubMed Web of Science ®Google Scholar
• Savic I, Nikolic G, Savic I, et al. Conductometric studies on the stability of copper complexes with different oligosaccharides. Open Chem. 2010;8(5):1078–1085.
   Google Scholar
• Li H, Xi D, Niu Y, et al. Design, synthesis and biological evaluation of cobalt (II)-Schiff base complexes as ATP-noncompetitive MEK1 inhibitors. J Inorg Biochem. 2019;195:174–181.
   PubMed Web of Science ®Google Scholar
• Iftikhar B, Javed K, Khan MSU, et al. Synthesis, characterization and biological assay of salicylaldehyde schiff base Cu (II) complexes and their precursors. J Mol Struct. 2018;1155:337–348.
   Web of Science ®Google Scholar
• Budzisz E. Role of metal ions complexes and their ligands in medicine, pharmacy and cosmetology. Curr Med Chem. 2019;26(4):578–579.
   PubMed Web of Science ®Google Scholar
• Al‐Busafi SN, Suliman FEO, Al‐Alawi ZR. 8‐hydroxyquinoline and its derivatives: synthesis and applications. ChemInform. 2014;45:1–10.
   Google Scholar
• Andersen A. Final amended report on the safety assessment of oxyquinoline and oxyquinoline sulfate as used in cosmetics. Int J Toxicol. 2006;25:1–9.
   PubMed Web of Science ®Google Scholar
• Chan SH, Chui CH, Chan SW, et al. Synthesis of 8-hydroxyquinoline derivatives as novel antitumor agents. ACS Med Chem Lett. 2012;4:170–174.
   PubMed Web of Science ®Google Scholar
• Shah P, Abadi LF, Gaikwad S, et al. Synthesis and biological evaluation of 8‐hydroxyquinoline‐hydrazones for anti‐HIV‐1 and anticancer potential. Chemistryselect. 2018;3:10727–10731.
   Web of Science ®Google Scholar
• Yang X, Cai P, Liu Q, et al. Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer’s disease. Bioorgan Med Chem. 2018;26:3191–3201.
   PubMed Web of Science ®Google Scholar
• Oliveri V, Vecchio G. 8-Hydroxyquinolines in medicinal chemistry: a structural perspective. Eur J Med Chem. 2016;120:252–274.
   PubMed Web of Science ®Google Scholar
• Chan-On W, Huyen NTB, Songtawee N, et al. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells. Drug Des Dev Ther. 2015;9:2033–2047.
   PubMed Web of Science ®Google Scholar
• Cherdtrakulkiat R, Lawung R, Nabu S, et al. Nitroxoline: a potent antimicrobial agent against multidrug resistant enterobacteriaceae. Excli J. 2019;18:445–453.
   PubMed Web of Science ®Google Scholar
• Lawung R, Cherdtrakulkiat R, Nabu S, et al. Repositioning of 8-hydroxyquinoline derivatives as a new promising candidate for combating multidrug resistant Neisseria gonorrhoeae. Excli J. 2018;17:840–846.
   PubMed Web of Science ®Google Scholar
• Krishna P. Chemoselective synthesis of 5-amino-7-bromoquinolin-8-yl sulfonate derivatives and their antimicrobial evaluation. Phosphorus Sulfur Silicon Relat Elem. 2018;193:685–690.
   Web of Science ®Google Scholar
• Krawczyk M, Pastuch-Gawolek G, Mrozek-Wilczkiewicz A, et al. Synthesis of 8-hydroxyquinoline glycoconjugates and preliminary assay of their β1, 4-GalT inhibitory and anti-cancer properties. Bioorg Chem. 2019;84:326–338.
   PubMed Web of Science ®Google Scholar
• Ali H, Khan E, Sajad MA. Phytoremediation of heavy metal-concepts and applications. Chemosphere. 2013;91(7):869–881.
   PubMed Web of Science ®Google Scholar
• Bleackley MR, MacGillivray RT. Transition metal homeostasis: from yeast to human disease. Biometals. 2011;24(5):785–809.
   PubMed Web of Science ®Google Scholar
• Sarwar N, Imran M, Shaheen MR, et al. Phytoremediation strategies for soils contaminated with heavy metals: modifications and future perspectives. Chemosphere. 2017;171:710–721.
   PubMed Web of Science ®Google Scholar
• Chobot V, Hadacek F, Bachmann G, et al. Antioxidant properties and the formation of iron coordination complexes of 8-hydroxyquinoline. Int J Mol Sci. 2018;19:3917–3926.
   Web of Science ®Google Scholar
• Prachayasittikul V, Prachayasittikul S, Ruchirawat S, et al. 8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications. Drug Des Dev Ther. 2013;7:1157–1178.
   PubMed Web of Science ®Google Scholar
• Musiol R. An overview of quinoline as a privileged scaffold in cancer drug discovery. Expert Opin Drug Dis. 2017;12(6):583–597.
   PubMed Web of Science ®Google Scholar
• Pithadia AS, Lim MH. Metal-associated amyloid-β species in Alzheimer’s disease. Curr Opin Chem Biol. 2012;16(1–2):67–73.
   PubMed Web of Science ®Google Scholar
• Suwanjang W, Prachayasittikul S, Prachayasittikul V. Effect of 8-hydroxyquinoline and derivatives on human neuroblastoma SH-SY5Y cells under high glucose. Peer J. 2016;4:e2389.
   PubMed Web of Science ®Google Scholar
• Luo T, Lei L, Chen F, et al. Iron homeostasis in the human body and nutritional iron deficiency and solutions in China. Journal of Food Biochem. 2018;42(6):e12673.
   Web of Science ®Google Scholar
• Crisponi G, Nurchi VM, Lachowicz JI. Iron chelation for iron overload in thalassemia. In: editor. Essential Metals in Medicine: therapeutic use and toxicity of metal ions in the clinic. Vol. 19. Boston, MA, USA; Berlin, Germany: De Gruyter; 2019. p. 49.
   Google Scholar
• Cilibrizzi A, Abbate V, Chen YL, et al. Hydroxypyridinone journey into metal chelation. Chem Rev. 2018;118(16):7657–7701.
   PubMed Web of Science ®Google Scholar
• Amolegbe SA, Adewuyi S, Akinremi CA, et al. Iron (III) and copper (II) complexes bearing 8-quinolinol with amino-acids mixed ligands: synthesis, characterization and antibacterial investigation. Arab J Chem. 2015;8:742–747.
   Web of Science ®Google Scholar
• Murakami K, Haneda M, Yoshino M. Prooxidant action of xanthurenic acid and quinoline compounds: role of transition metals in the generation of reactive oxygen species and enhanced formation of 8-hydroxy-2′-deoxyguanosine in DNA. Biometals. 2006;19:429–435.
   PubMed Web of Science ®Google Scholar
• Zhang HR, Meng T, Liu YC, et al. Synthesis, structure characterization and antitumor activity study of a new iron (III) complex of 5-nitro-8-hydroxylquinoline (HNOQ). Chem Pharm Bull. 2016;64:1208–1217.
   PubMed Web of Science ®Google Scholar
• Zou BQ, Qin QP, Bai YX, et al. Synthesis and antitumor mechanism of a new iron (III) complex with 5, 7-dichloro-2-methyl-8-quinolinol as ligands. Med Chem Comm. 2017;8:633–639.
   Google Scholar
• Ozbolat G, Tuli A. Iron chelating ligand for iron overload diseases. Bratisl Med J. 2018;119:308–311.
   Google Scholar
• Barilli A, Atzeri C, Bassanetti I, et al. Oxidative stress induced by copper and iron complexes with 8-hydroxyquinoline derivatives causes paraptotic death of HeLa cancer cells. Mol Pharm. 2014;11:1151–1163.
   PubMedGoogle Scholar
• Mrozek-Wilczkiewicz A, Kuczak M, Malarz K, et al. The synthesis and anticancer activity of 2-styrylquinoline derivatives. A p53 independent mechanism of action. Eur J Med Chem. 2019;177:338–349.
   PubMed Web of Science ®Google Scholar
• Mrozek-Wilczkiewicz A, Spaczynska E, Malarz K, et al. Design, synthesis and in vitro activity of anticancer styrylquinolines. The p53 independent mechanism of action. PloS One. 2015;10(11):e0142678. 1–14.
   PubMed Web of Science ®Google Scholar
• Musiol R, Jampilek J, Buchta V, et al. Antifungal properties of new series of quinoline derivatives. Bioorgan Med Chem. 2006;14(10):3592–3598.
   PubMed Web of Science ®Google Scholar
• Musiol R, Serda M, Hensel-Bielowka S, et al. Quinoline-based antifungals. Curr Med Chem. 2010;17(18):1960–1973.
   PubMed Web of Science ®Google Scholar
• Mouscadet JF, Desmaële D. Chemistry and structure-activity relationship of the styrylquinoline-type HIV integrase inhibitors. Molecules. 2010;15(5):3048–3078.
   PubMed Web of Science ®Google Scholar
• Kurczyk A, Warszycki D, Musiol R, et al. Ligand-based virtual screening in a search for novel anti-HIV-1 chemotypes. J Chem Inf Model. 2015;55(10):2168–2177.
   PubMed Web of Science ®Google Scholar
• Polanski J, Niedbala H, Musiol R, et al. 5-Hydroxy-6-quinaldic acid as a novel molecular scaffold for HIV-1 integrase inhibitors. Lett Drug Des Discov. 2006;3(3):175–178.
   Web of Science ®Google Scholar
• Pape VF, May NV, Gál GT, et al. Impact of copper and iron binding properties on the anticancer activity of 8-hydroxyquinoline derived Mannich bases. Dalton T. 2018;47:17032–17045.
   PubMed Web of Science ®Google Scholar
• Bhowmik D, Chiranjib KP, Kumar S. A potential medicinal importance of zinc in human health and chronic. Int J Pharm. 2010;1(1):5–11.
   Google Scholar
• Sensi SL, Granzotto A, Siotto M, et al. Copper and zinc dysregulation in Alzheimer’s disease. Trends Pharmacol Sci. 2018;39(12):1049–1063.
   PubMed Web of Science ®Google Scholar
• Staderini M, Aulić S, Bartolini M, et al. A fluorescent styrylquinoline with combined therapeutic and diagnostic activities against Alzheimer’s and Prion diseases. ACS Med Chem Lett. 2013;4(2):225–229.
   PubMed Web of Science ®Google Scholar
• Ritchie CW, Bush AI, Mackinnon A, et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Aβ amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol. 2003;60:1685–1691.
   PubMed Web of Science ®Google Scholar
• De Freitas LV, Dos Santos ALDS, Da Costa FC, et al. Synthesis and structural characterization of a 8-hydroxyquinoline derivative coordinated to Zn (II). J Mol Struct. 2018;1169:119–129.
   Web of Science ®Google Scholar
• Sgarlata C, Oliveri V, Spencer J. A 8‐hydroxyquinoline‐cyclodextrin conjugate as an efficient chelating agent for cobalt (II) and nickel (II) in neutral aqueous solution. Eur J Inor Chem. 2015;2015:5886–5891.
   Google Scholar
• Oliveri V, Pietropaolo A, Sgarlata C, et al. Zinc complexes of cyclodextrin‐bearing 8‐hydroxyquinoline ligands: a comparative study. Chem Asian J. 2017;12:110–115.
   PubMed Web of Science ®Google Scholar
• Ahmad W, Khan SA, Munawar KS, et al. Synthesis, characterization and pharmacological evaluation of mixed ligand-metal complexes containing omeprazole and 8-hydroxyquinoline. Trop J Pharm Res. 2017;16:1137–1146.
   Web of Science ®Google Scholar
• Mandewale MC, Thorat B, Shelke D, et al. Synthesis and biological evaluation of new hydrazone derivatives of quinoline and their Cu (II) and Zn (II) complexes against Mycobacterium tuberculosis. Bioinorg Chem Appl. 2015;2015:1–14, Article ID 153015
   Google Scholar
• Marzano C, Pellei M, Tisato F, et al. Copper complexes as anticancer agents. Anti-Cancer Agent Me. 2009;9:185–211.
   PubMed Web of Science ®Google Scholar
• Cakic M, Mitic Z, Nikolic G, et al. Design and optimization of drugs used to treat copper deficiency. Expert Opin Drug Dis. 2013;8:1253–1263.
   PubMed Web of Science ®Google Scholar
• Savic IM, Nikolic GS, Savic IM, et al. Development and optimization of formulation for treatment of copper deficiency in human organism. Acta Pol Pharm Drug Res. 2012;69:739–749.
   PubMed Web of Science ®Google Scholar
• Savic IM, Nikolic K, Nikolic G, et al. Application of mathematical modeling for the development and optimization formulation with bioactive copper complex. Drug Dev Ind Pharm. 2013;39:1084–1090.
   PubMed Web of Science ®Google Scholar
• Cao Y, Skaug MA, Andersen O, et al. Chelation therapy in intoxications with mercury, lead and copper. J Trace Elem Med Bio. 2015;31:188–192.
   PubMed Web of Science ®Google Scholar
• Budimir A, Humbert N, Elhabiri M, et al. Hydroxyquinoline based binders: promising ligands for chelatotherapy? J Inorg Biochem. 2011;105:490–496.
   PubMed Web of Science ®Google Scholar
• Crouch PJ, Barnham KJ. Therapeutic redistribution of metal ions to treat Alzheimer’s disease. Acc Chem Res. 2012;45:1604–1611.
   PubMed Web of Science ®Google Scholar
• Prachayasittikul V, Pingaew R, Nantasenamat C, et al. Investigation of aromatase inhibitory activity of metal complexes of 8-hydroxyquinolineand uracil derivatives. Drug Des Dev Ther. 2014;8:1089–1096.
   PubMed Web of Science ®Google Scholar
• Shah S, Dalecki AG, Malalasekera AP, et al. 8-Hydroxyquinolines are boosting agents of copper-related toxicity in Mycobacterium tuberculosis. Antimicrob Agents Ch. 2016;60(10):5765–5776.
   PubMed Web of Science ®Google Scholar
• Correia I, Adao P, Roy S, et al. Hydroxyquinoline derived vanadium (IV and V) and copper (II) complexes as potential anti-tuberculosis and anti-tumor agents. J Inorg Biochem. 2014;141:83–93.
   PubMed Web of Science ®Google Scholar
• Rogolino D, Cavazzoni A, Gatti A, et al. Anti-proliferative effects of copper (II) complexes with hydroxyquinoline-thiosemicarbazone ligands. Eur J Med Chem. 2017;128:140–153.
   PubMed Web of Science ®Google Scholar
• Oliveri V, Lanza V, Milardi D, et al. Amino-and chloro-8-hydroxyquinolines and their copper complexes as proteasome inhibitors and antiproliferative agents. Metallomics. 2017;9:1439–1446.
   PubMed Web of Science ®Google Scholar
• Deka B, Sarkar T, Banerjee S, et al. Novel mitochondria targeted copper (II) complexes of ferrocenyl terpyridine and anticancer active 8-hydroxyquinolines showing remarkable cytotoxicity, DNA and protein binding affinity. Dalton T. 2017;46:396–409.
   PubMed Web of Science ®Google Scholar
• Xie F, Cai H, Peng F. Anti-prostate cancer activity of 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide copper complexes in vivo by bioluminescence imaging. J Biol Inorg Chem. 2018;23:949–956.
   PubMed Web of Science ®Google Scholar
• Pastuch-Gawołek G, Malarz K, Mrozek-Wilczkiewicz A, et al. Small molecule glycoconjugates with anticancer activity. Eur J Med Chem. 2016;112:130–144.
   PubMed Web of Science ®Google Scholar
• Srisung S, Suksrichavalit T, Prachayasittikul S, et al. Antimicrobial activity of 8-hydroxyquinoline and transition metal complexes. Int J Pharmacol. 2013;9:170–175.
   Web of Science ®Google Scholar
• Jyotirmaya S, Nandini SPK, Kumar PS. In vitro antimicrobial investigations of newly synthesized transitional bivalent metal complexes derived from 8-hydroxyquinoline. Indian J Pharm Educ. 2017;51:480–489.
   Google Scholar
• Worachartcheewan A, Pingaew R, Lekcharoen D, et al. Synthesis, antioxidant and antimicrobial activities of metal complexes of 2-thiouracil-hydroxyquinoline derivatives. Lett Drug Des Discov. 2018;15:602–611.
   Web of Science ®Google Scholar
• Pippi B, Reginatto P, Machado GDRM, et al. Evaluation of 8-hydroxyquinoline derivatives as hits for antifungal drug design. Med Mycol. 2017;55:763–773.
   PubMed Web of Science ®Google Scholar
• Bareggi SR, Cornelli U. Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. Cns Neurosci Ther. 2012;18:41–46.
   PubMed Web of Science ®Google Scholar
• Chang WL, Hsu LC, Leu WJ, et al. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer–a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation. Oncotarget. 2015;6:39806–39820.
   PubMedGoogle Scholar
• Lazovic J, Guo L, Nakashima J, et al. Nitroxoline induces apoptosis and slows glioma growth in vivo. Neuro Oncol. 2014;17:53–62.
   PubMed Web of Science ®Google Scholar
• Jiang H, Taggart JE, Zhang X, et al. Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline). Cancer Lett. 2011;312:11–17.
   PubMed Web of Science ®Google Scholar
• Venkateswarlu I, Jayashankar RV, Ramesh Y, et al. A review on liposomes. Res J Pharm Biol Chem Sci. 2011;2:739–751.
   Google Scholar
• Pathak N, Pathak P. Applications liposome in cancer drug delivery and treatment: a review. Asian J Pharm Res Develop. 2019;7:62–65.
   Google Scholar
• Oliveri V, Bellia F, Vecchio G. Cyclodextrin nanoparticles bearing 8‐hydroxyquinoline ligands as multifunctional biomaterials. Chem Eur J. 2017;23:4442–4449.
   PubMed Web of Science ®Google Scholar
• Wehbe M, Malhotra AK, Anantha M, et al. Development of a copper-clioquinol formulation suitable for intravenous use. Drug Deliv Transl Re. 2018;8:239–251.
   PubMed Web of Science ®Google Scholar
• Nikolic IL, Savic IM, Popsavin MM, et al. Preparation, characterization and antimicrobial activity of inclusion complex of biochanin A with (2‐hydroxypropyl)‐β‐cyclodextrin. J Pharm Pharmacol. 2018;70:1485–1493.
   PubMed Web of Science ®Google Scholar
• Savic IM, Jocic E, Nikolic VD, et al. The effect of complexation with cyclodextrins on the antioxidant and antimicrobial activity of ellagic acid. Pharm Dev Technol. 2019;24:410–418.
   PubMed Web of Science ®Google Scholar
• Ilić-Stojanović S, Nikolić V, Kundaković T, et al. Thermosensitive hydrogels for modified release of ellagic acid obtained from Alchemilla vulgaris L. extract. Int J Polym Mater Po. 2018;67:553–563.
   Web of Science ®Google Scholar
• Friggeri A, Feringa BL, van Esch J. Entrapment and release of quinoline derivatives using a hydrogel of a low molecular weight gelator. J Control Release. 2004;97:241–248.
   PubMed Web of Science ®Google Scholar
• Díaz DD, Morin E, Schön EM, et al. Tailoring drug release profile of low-molecular-weight hydrogels by supramolecular co-assembly and thiolene orthogonal coupling. J Mater Chem. 2011;21:641–644.
   Web of Science ®Google Scholar
• Kulkarni PV, Roney CA, Antich PP, et al. Quinoline‐n‐butylcyanoacrylate‐based nanoparticles for brain targeting for the diagnosis of Alzheimer’s disease. Wires Nanomed Nanobi. 2010;2:35–47.
   PubMed Web of Science ®Google Scholar
• Hua J, Teng P, Zou Y, et al. Small antimicrobial agents encapsulated in poly (epsilon-caprolactone)-poly (ethylene glycol) nanoparticles for treatment of S. aureus-infected wounds. J Nanopart Res. 2018;20:270–284.
   Web of Science ®Google Scholar
• Elghazawy NH, Hefnawy A, Sedky NK, et al. Preparation and nanoformulation of new quinolone scaffold-based anticancer agents: enhancing solubility for better cellular delivery. Eur J Pharm Sci. 2017;105:203–211.
   PubMed Web of Science ®Google Scholar
• Chowdhury SR, Mukherjee S, Das S, et al. Multifunctional (3-in-1) cancer theranostics applications of hydroxyquinoline-appended polyfluorene nanoparticles. Chem Sci. 2017;8:7566–7575.
   PubMed Web of Science ®Google Scholar
• Duarte MC, Dos Reis Lage LM, Lage DP, et al. Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system. Parasitol Int. 2016;65:728–736.
   PubMed Web of Science ®Google Scholar
• Dos Reis Lage LM, Barichello JM, Lage D, et al. An 8-hydroxyquinoline-containing polymeric micelle system is effective for the treatment of murine tegumentary leishmaniasis. Parasitol Res. 2016;115:4083–4095.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang Y, Kumar A, et al. pH-sensitive nano-systems for drug delivery in cancer therapy. Biotechnol Adv. 2014;32:693–710.
   PubMed Web of Science ®Google Scholar
• Weerasuriya DRK, Wijesinghe WPSL, Rajapakse RMG. Encapsulation of anticancer drug copper bis (8-hydroxyquinoline) in hydroxyapatite for pH-sensitive targeted delivery and slow release. Mater Sci Eng C. 2017;71:206–213.
   PubMed Web of Science ®Google Scholar
• Hu D, Xu H, Xiao B, et al. Albumin-stabilized metal–organic nanoparticles for effective delivery of metal complex anticancer drugs. ACS Appl Mater Inter. 2018;10:34974–34982.
   PubMed Web of Science ®Google Scholar
• Pan UN, Sanpui P, Paul A, et al. Surface-complexed zinc ferrite magnetofluorescent nanoparticles for killing cancer cells and single-particle-level cellular imaging. ACS Appl Nano Mater. 2018;1:2496–2502.
   Web of Science ®Google Scholar
• Kiasat AR, Mirzajani R, Ataeian F, et al. Immobilized silver nanoparticles on silica gel as an efficient catalyst in nitroarene reduction. Chinese Chem Lett. 2010;21:1015–1019.
   Web of Science ®Google Scholar
• Dahlous KA, Abd-Elkader OH, Fouda MM, et al. Eco-friendly method for silver nanoparticles immobilized decorated silica: synthesis & characterization and preliminary antibacterial activity. J Taiwan Ins Chem E. 2019;95:324–331.
   Web of Science ®Google Scholar
• Yang L, Yin T, Liu Y, et al. Gold nanoparticle-capped mesoporous silica-based H2O2-responsive controlled release system for Alzheimer’s disease treatment. Acta Biomater. 2016;46:177–190.
   PubMed Web of Science ®Google Scholar